Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-342.99M
↓ 53% below average
Average (5y)
$-224.14M
Historical baseline
Range
High:$-129.38M
Low:$-342.99M
CAGR
+21.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-342.99M | -46.2% |
| 2023 | $-234.63M | -28.1% |
| 2022 | $-183.12M | +26.8% |
| 2021 | $-250.22M | -22.4% |
| 2020 | $-204.47M | -58.0% |
| 2019 | $-129.38M | - |